These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 12141721

  • 21. Triamcinolone acetonide aqueous nasal spray and fluticasone propionate are equally effective for relief of nasal symptoms in patients with seasonal allergic rhinitis.
    Berger WE, Kaiser H, Gawchik SM, Tillinghast J, Woodworth TH, Dupclay L, Georges GC.
    Otolaryngol Head Neck Surg; 2003 Jul; 129(1):16-23. PubMed ID: 12869911
    [Abstract] [Full Text] [Related]

  • 22. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [Abstract] [Full Text] [Related]

  • 23. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 24. Triamcinolone acetonide and fluticasone propionate aqueous nasal sprays significantly improve nasal airflow in patients with seasonal allergic rhinitis.
    Meltzer EO, Gallet CL, Jalowayski AA, Garcia J, Diener P, Liao Y, Georges G.
    Allergy Asthma Proc; 2004 May; 25(1):53-8. PubMed ID: 15055563
    [Abstract] [Full Text] [Related]

  • 25. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis.
    Findlay S, Huber F, Garcia J, Huang L.
    Ann Allergy; 1992 Mar; 68(3):228-32. PubMed ID: 1546817
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis.
    Nayak AS, Ellis MH, Gross GN, Mendelson LM, Schenkel EJ, Lanier BQ, Simpson B, Mullin ME, Smith JA.
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):157-62. PubMed ID: 9500747
    [Abstract] [Full Text] [Related]

  • 33. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension.
    Weinstein S, Qaqundah P, Georges G, Nayak A.
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):339-47. PubMed ID: 19441606
    [Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR.
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
    [Abstract] [Full Text] [Related]

  • 36. A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis.
    Lumry W, Hampel F, LaForce C, Kiechel F, el-Akkad T, Murray JJ.
    Allergy Asthma Proc; 2003 Dec; 24(3):203-10. PubMed ID: 12866325
    [Abstract] [Full Text] [Related]

  • 37. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [Abstract] [Full Text] [Related]

  • 38. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [Abstract] [Full Text] [Related]

  • 39. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis.
    Potter PC, Van Niekerk CH, Schoeman HS.
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):368-74. PubMed ID: 14582816
    [Abstract] [Full Text] [Related]

  • 40. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R, Nathan RA, Schenkel E, Danzig MR, Gates D, Varghese S.
    Int Arch Allergy Immunol; 2008 Oct; 147(4):323-30. PubMed ID: 18622139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.